Back to search

National and Kapodistrian University of Athens

Συγκριτική μελέτη μακρού και βραχέος οισοφάγου Barrett ως προς επιδημιολογικές, κλινικές, ιστολογικές και ανοσοϊστοχημικές παραμέτρους

Abstract

dc:description

Barrett’s esophagus (BE) is the most severe complication of gastroesophageal reflux disease (GERD). The normal squamous epithelium of the distal esophagus is replaced by columnar with intestinal metaplasia. BE is a definite precancerous lesion, although the incidence of cancer is ultimately low. Factors that may predict an unfavorable course are intensively looked for over the past years. Barrett’s variable length has long been considered intriguing in terms of both pathogenesis and malignant potential. The aim of our study was to determine clinical, endoscopic, histological and immunohistochemical parameters that correlate to Barrett’s length. Methods: Endoscopy archives from 1996 to 2003 were retrospectively searched for patients with histologically confirmed BE. The diagnosis was confirmed by two experienced pathologists who additionally evaluated inflammatory infiltration. Immunohistochemistry was performed for vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2) and Ki-67. A qualitative scale was applied for the evaluation of inflammation and immunohistochemistry: mild, moderate, strong. Results: The study population consisted of 98 patients. 78 patients were male (79.5%) and the mean age was 58.3 ± 13.3 yrs. Long segments (LSBE) were found in 33 cases (33.7%). 40 (40.8%) patients did not report reflux symptoms, whereas in 77 (78.5%) and 54 (55.1%) cases hiatal hernia and esophagitis were respectively diagnosed. 75 (76.5%) and 12 (12.2%) patients systemically used PPIs/H2- blockers and aspirin/NSAIDs, respectively. Results of immunohistochemistry and the assessment of inflammation are depicted in the table. The comparative analysis showed that hiatal hernia (p=0.001), esophagitis (p=0.019) and use of PPIs/H2- blockers (p=0.005) correlated with LSBE. Increased number of small, VEGF-positive vessels was associated to short BE (SSBE) (p=0.031), whereas increased immunohistochemical expression of Ki-67 correlated with LSBE (p=0.035). Conclusions: 1) Strong immunohistochemical expression of VEGF correlated with SSBE. Neo-angiogenesis may in part explain short Barrett’s malignant potential. 2) Strong immunohistochemical expression of Ki-67 correlated with LSBE. This finding may reflect an increased risk of neoplastic progression. 3) Hiatal hernia, esophagitis and previous use of anti-reflux medications were more commonly found in patients with LSBE.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ζαμπέλη, Ευανθία
  • Zambeli, Evanthia

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27789

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ζαμπέλη, Ευανθία; Zambeli, Evanthia. Συγκριτική μελέτη μακρού και βραχέος οισοφάγου Barrett ως προς επιδημιολογικές, κλινικές, ιστολογικές και ανοσοϊστοχημικές παραμέτρους. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27789